Terms of reference for Data and Safety Monitoring Committees

American Heart Journal

Volumn 141, Issue 4, 2001, Pages 542-547

  Packer, Milton ^a   Wittes, Janet ^b   Stump, David ^c  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b University of Iowa   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPREHENSION; CONFERENCE PAPER; CONFIDENTIALITY; NOMENCLATURE; PATIENT MONITORING; POLITICS; PRIORITY JOURNAL; RESPONSIBILITY;

EID: 0035094581     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.113838     Document Type: Conference Paper

References (17)

1. NHLI BARI clinical alert on diabetics treated with angioplasty
2. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction: The GUSTO investigators
3. Design and methodology of the PURSUIT trial: Evaluating eptifibatide for acute ischemic coronary syndromes. Platelet glycoprotein IIb-IIIa in unstable angina: Receptor suppression using integrilin therapy
4. Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study
5. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction: Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs Symptoms (PRISM-PLUS) Study Investigators
6. The agonising negative trend in monitoring of clinical trials
7. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
8. Routine medical management of acute myocardial infarction: Lessons from overviews of recent randomized controlled trials
9. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
10. Data monitoring in clinical trials: Which treatment is better?
11. Vitamin E supplementation and cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
12. Preliminary report: Findings for the aspirin component of the ongoing Physicians' Health Study
13. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
14. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes: The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators
15. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI) Investigators
16. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI)